ImmPACT Bio reels in $111M to prevent tumor escape with novel cell therapies January 20, 2022 Auto Bot BioPharma, biopharma nl, California, cancer, CAR-T, cell therapy, Clinical Trials, deals, investing, Pharma, venture capital 0 Despite the targeted approach of some cancer treatments, tumors can find ways to escape, leading patients to relapse. ImmPACT Bio will apply its Series B financing toward the development of cell therapies designed to prevent tumor escape.